MedPath

Early Neurocognitive Rehabilitation in Intensive Care

Not Applicable
Completed
Conditions
Critical Illness
Interventions
Other: Neurocognitive stimulation
Registration Number
NCT02078206
Lead Sponsor
Corporacion Parc Tauli
Brief Summary

The purpose of this project is to assess the efficacy of an early neurocognitive intervention for ICU patients, in terms of psychopathological, neuropsychological and functional improvement. The treatment is supported in an interactive advanced computing platform that includes the continuous biomedical registration of the patients and a virtual reality software specifically designed for critical patients.

The investigators expect an improvement in neuropsychological, psychopathological and functional status at hospital discharge and 3 months follow-up in those patients that have received the early neurocognitive intervention comparing with patients treated as usual. Furthermore the investigators expect a decrease of episodes and/or duration of delirium in ICU patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
72
Inclusion Criteria
  • Patients aged between 18 and 80 years
  • Patients receiving mechanical ventilation for at least 24 hours
  • Patients scoring more than 8 on the Glasgow Coma Scale (GCS) and more than 2 on the Sedation Agitation Scale (SAS)
  • Patients haemodynamically stable
  • Informed consent signed by the closest relatives.
Exclusion Criteria
  • Patients with previous neurologic pathology or focal brain injury before ICU admission
  • Patients with serious psychiatric pathology (major depression, psychosis, bipolar disease) or mentally retarded
  • Patients with sensorial alterations needed to interact with the neurocognitive stimulation programme
  • patients whose closest relatives refuse the subject to be included in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Neurocognitive stimulationNeurocognitive stimulationIntervention of experimental group consists in a neurocognitive stimulation treatment. Using kinect technology, patient can interact with a virtual environment where different cognitive tasks have to be resolved.
Primary Outcome Measures
NameTimeMethod
Speed processingHospital discharge and 3-months after hospital discharge

- Information processing speed: Symbol Search subtest of the WAIS III (Wechsler, 1999)

Functional Statushospital discharge and 3-months after hospital discharge

* Quality of life questionnaire: Satisfaction and Pleasure (Q-LES-Q) (Endicott, J., Nee, J., Harrison, W. \& Blumenthal, R., 1993)

* Lawton and Brody Functional Scale (1969)

AttentionHospital discharge and 3-months after hospital discharge

* Verbal attention: Digits Forward subtest of the WAIS III (Wechsler, 1999)

* Visual attention: Spatial Localization Forward subtest of the WMS III (Wechsler, 1999)

* Sustained/Selective attention: Continuous Performance Test (Conners, 1992)

Psychopathological statusHospital discharge and 3-monts after hospital discharge

* Depression: Hamilton Depression Rating Scale (HDRS) (Hamilton, 1960)

* Anxiety: Hamilton Anxiety Rating Scale (HAM-A) (Hamilton, 1959)

MemoryHospital discharge and 3-months after hospital disharge

* Verbal learning and memory: Auditory Verbal Learning Test (Rey, 1964)

* Visual learning and memory: 10/36 Spatial Recall Test (Rao, 1992)

* Visual recognition: Benton Visual Retention Test (Benton, 1983)

Executive FunctionsHospital discharge and 3-months after hospital discharge

* Stimuli alternation and sequencing: Trail Making Test A-B (Mimeo \& Manga, 1999)

* Automatic inhibition response: Stroop Test (Golden \& Charles, 1978)

* Visual planning: Tower of London (Shallice, 1982).

* Phonetic verbal fluency: FAS test (Spreen and Benton, 1995)

* Semantic verbal fluency: Animals 1' (Benton \& Hamsher, 1976)

Secondary Outcome Measures
NameTimeMethod
DeliriumEvery day during ICU stay

Number of episodes and duration of delirium: Confusional Assessment Method for Intensive Care Unit (CAM-ICU)

Trial Locations

Locations (1)

Corporació Parc Taulí

🇪🇸

Sabadell, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath